These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34792910)

  • 1. [What do we know about effects of the endocrine disruptors on metabolism and obesity?].
    Kim MJ; Blanc É; Audouze K
    Rev Prat; 2021 Sep; 71(7):740-746. PubMed ID: 34792910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EDCMET Project: Metabolic Effects of Endocrine Disruptors.
    Küblbeck J; Vuorio T; Niskanen J; Fortino V; Braeuning A; Abass K; Rautio A; Hakkola J; Honkakoski P; Levonen AL
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on endocrine disruptor effects on metabolic sensors.
    Migliarini B; Piccinetti CC; Martella A; Maradonna F; Gioacchini G; Carnevali O
    Gen Comp Endocrinol; 2011 Feb; 170(3):416-23. PubMed ID: 21130769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative Strategy of Testing Systems for Identification of Endocrine Disruptors Inducing Metabolic Disorders-An Introduction to the OBERON Project.
    Audouze K; Sarigiannis D; Alonso-Magdalena P; Brochot C; Casas M; Vrijheid M; Babin PJ; Karakitsios S; Coumoul X; Barouki R
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental endocrine disruptors and obesity.
    Karoutsou E; Polymeris A
    Endocr Regul; 2012 Jan; 46(1):37-46. PubMed ID: 22329821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine Disruptors Leading to Obesity and Related Diseases.
    Petrakis D; Vassilopoulou L; Mamoulakis C; Psycharakis C; Anifantaki A; Sifakis S; Docea AO; Tsiaoussis J; Makrigiannakis A; Tsatsakis AM
    Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29064461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of Mytilus digestive gland cells for the in vitro screening of potential metabolic disruptors in aquatic invertebrates.
    Balbi T; Ciacci C; Grasselli E; Smerilli A; Voci A; Canesi L
    Comp Biochem Physiol C Toxicol Pharmacol; 2017 Jan; 191():26-35. PubMed ID: 27626137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial pathway disruption is a powerful approach to delineate metabolic impacts of endocrine disruptors.
    Bernal K; Touma C; Erradhouani C; Boronat-Belda T; Gaillard L; Al Kassir S; Le Mentec H; Martin-Chouly C; Podechard N; Lagadic-Gossmann D; Langouet S; Brion F; Knoll-Gellida A; Babin PJ; Sovadinova I; Babica P; Andreau K; Barouki R; Vondracek J; Alonso-Magdalena P; Blanc E; Kim MJ; Coumoul X
    FEBS Lett; 2022 Dec; 596(24):3107-3123. PubMed ID: 35957500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global pollution by organochlorinated endocrine disruptors - possible challenge for mankind at the onset of millennium.
    Langer P
    Endocr Regul; 2015 Jan; 49(1):25-36. PubMed ID: 25687678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of and Challenges in Regulating Endocrine Disruptors - How Regulators and Industry Can Conquer?
    Dhiman SK; Dureja H
    Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1664-1681. PubMed ID: 32504507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bisphenol A on metabolism and evidences of a mode of action mediated through endocrine disruption.
    Le Magueresse-Battistoni B; Multigner L; Beausoleil C; Rousselle C
    Mol Cell Endocrinol; 2018 Nov; 475():74-91. PubMed ID: 29481862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative environmental-endocrine disruptors and obesity: a review.
    Elobeid MA; Allison DB
    Curr Opin Endocrinol Diabetes Obes; 2008 Oct; 15(5):403-8. PubMed ID: 18769210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine Disruptors and Obesity.
    Darbre PD
    Curr Obes Rep; 2017 Mar; 6(1):18-27. PubMed ID: 28205155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endocrine Disruptors: what are we talking about and what new mecanisms of toxicity do they bring into play?].
    Barouki R; Audouze K; Coumoul X
    Rev Prat; 2021 Sep; 71(7):723-726. PubMed ID: 34792906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontiers in endocrine disruption: Impacts of organotin on the hypothalamus-pituitary-thyroid axis.
    Santos-Silva AP; Andrade MN; Pereira-Rodrigues P; Paiva-Melo FD; Soares P; Graceli JB; Dias GRM; Ferreira ACF; de Carvalho DP; Miranda-Alves L
    Mol Cell Endocrinol; 2018 Jan; 460():246-257. PubMed ID: 28774778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesogenic endocrine disruptors and obesity: myths and truths.
    Muscogiuri G; Barrea L; Laudisio D; Savastano S; Colao A
    Arch Toxicol; 2017 Nov; 91(11):3469-3475. PubMed ID: 28975368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to endocrine-disrupting compounds such as phthalates and bisphenol A is associated with an increased risk for obesity.
    Biemann R; Blüher M; Isermann B
    Best Pract Res Clin Endocrinol Metab; 2021 Sep; 35(5):101546. PubMed ID: 33966978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose Tissue and Endocrine-Disrupting Chemicals: Does Sex Matter?
    Le Magueresse-Battistoni B
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33333918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker genes for detecting estrogenic activity of endocrine disruptors via estrogen receptors.
    Jung EM; An BS; Yang H; Choi KC; Jeung EB
    Int J Environ Res Public Health; 2012 Mar; 9(3):698-711. PubMed ID: 22690157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesogen effect of bisphenol S alters mRNA expression and DNA methylation profiling in male mouse liver.
    Brulport A; Vaiman D; Chagnon MC; Le Corre L
    Chemosphere; 2020 Feb; 241():125092. PubMed ID: 31683443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.